» Articles » PMID: 27525095

An 8.4-Mb 3q26.33-3q28 Microdeletion in a Patient with Blepharophimosis-intellectual Disability Syndrome and a Review of the Literature

Overview
Journal Clin Case Rep
Date 2016 Aug 16
PMID 27525095
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

3q26.33-3q27.2 microdeletion can be classified as a clinical entity characterized by intrauterine growth retardation, feeding problems in infancy, short stature, intellectual disability, hypotonia, dysmorphic facial features (medially sparse eyebrows, narrow horizontal palpebral fissures, epicanthal folds, flat nasal bridge and tip, short philtrum, and downturned corners of mouth), and teeth and feet abnormalities.

Citing Articles

Etiologic evaluation and pregnancy outcomes of fetal growth restriction (FGR) associated with structural malformations.

Wu X, He S, Shen Q, Xu S, Guo D, Liang B Sci Rep. 2024; 14(1):9220.

PMID: 38649697 PMC: 11035600. DOI: 10.1038/s41598-024-59422-8.


Defective binding of ETS1 and STAT4 due to a mutation in the promoter region of as a novel mechanism of congenital amegakaryocytic thrombocytopenia.

Capaci V, Adam E, Bar-Joseph I, Faleschini M, Pecci A, Savoia A Haematologica. 2022; 108(5):1385-1393.

PMID: 36226497 PMC: 10153527. DOI: 10.3324/haematol.2022.281392.


3q27.1 microdeletion causes prenatal and postnatal growth restriction and neurodevelopmental abnormalities.

Barua S, Pereira E, Jobanputra V, Anyane-Yeboa K, Levy B, Liao J Mol Cytogenet. 2022; 15(1):7.

PMID: 35241116 PMC: 8895857. DOI: 10.1186/s13039-022-00587-0.


Infantile presentation of 3q26.33-3q27.2 deletion syndrome.

Robilliard R, Caylan M BMJ Case Rep. 2020; 13(11).

PMID: 33257348 PMC: 7705523. DOI: 10.1136/bcr-2019-233215.


Monoallelic loss-of-function THPO variants cause heritable thrombocytopenia.

Cornish N, Aungraheeta M, Fitzgibbon L, Burley K, Alibhai D, Collins J Blood Adv. 2020; 4(5):920-924.

PMID: 32150607 PMC: 7065488. DOI: 10.1182/bloodadvances.2019001293.

References
1.
Verloes A, Bremond-Gignac D, Isidor B, David A, Baumann C, Leroy M . Blepharophimosis-mental retardation (BMR) syndromes: A proposed clinical classification of the so-called Ohdo syndrome, and delineation of two new BMR syndromes, one X-linked and one autosomal recessive. Am J Med Genet A. 2006; 140(12):1285-96. DOI: 10.1002/ajmg.a.31270. View

2.
Miller D, Adam M, Aradhya S, Biesecker L, Brothman A, Carter N . Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet. 2010; 86(5):749-64. PMC: 2869000. DOI: 10.1016/j.ajhg.2010.04.006. View

3.
Clayton-Smith J, Krajewska-Walasek M, Fryer A, Donnai D . Ohdo-like blepharophimosis syndrome with distinctive facies, neonatal hypotonia, mental retardation and hypoplastic teeth. Clin Dysmorphol. 1994; 3(2):115-20. View

4.
Maat-Kievit A, Brunner H . Two additional cases of the Ohdo blepharophimosis syndrome. Am J Med Genet. 1993; 47(6):901-6. DOI: 10.1002/ajmg.1320470618. View

5.
Zarate Y, Bell C, Schaefer B . Description of another case of 3q26.33-3q27.2 microdeletion supports a recognizable phenotype. Eur J Med Genet. 2013; 56(11):624-5. DOI: 10.1016/j.ejmg.2013.09.004. View